Does untreated obstructive sleep apnea cause oxidative stress, mitochondrial impairment, and fatigue?

Obstructive sleep apnea (OSA) is characterized by repetitive upper airway collapses that trigger cyclic intermittent hypoxia and micro-arousal-induced sleep fragmentation.

Mechanistic pathways of cellular stress

• Oxidative Stress Amplification: Intermittent hypoxia and reoxygenation cycles mimic ischemia-reperfusion injuries, generating excess reactive oxygen species (ROS). Concurrently, sleep fragmentation independently promotes pro-inflammatory and pro-oxidative states, compounding systemic cellular redox imbalance.
• Mitochondrial Dysfunction and Feedback Loops: High oxidative stress directly damages mitochondrial DNA (mtDNA), structural membranes, and respiratory chain enzymes. In turn, damaged mitochondria generate additional ROS, establishing a pathological feedback loop. Furthermore, chronic intermittent hypoxia directly suppresses mitochondrial respiration, impairs fatty acid oxidation, and reduces ATP production.

Downstream clinical and metabolic impacts

• Systemic Fatigue: The impairment of mitochondrial oxidative phosphorylation limits cellular energy availability. This severe ATP deficit, particularly within skeletal muscle tissues, manifests clinically as profound daytime fatigue and exercise intolerance.
• Cardiometabolic Dysregulation: Mitochondrial impairment and associated oxidative stress alter substrate metabolism (favoring hepatic fatty acid oxidation over glucose) and cause lipid intermediate accumulation. These cellular changes directly promote insulin resistance, dyslipidemia, hepatic steatosis, and systemic endothelial dysfunction.

Bottom line

• Untreated obstructive sleep apnea initiates a cascade where intermittent hypoxia and sleep fragmentation drive oxidative stress and mitochondrial damage. This cellular energy depletion and metabolic reprogramming directly result in chronic fatigue, insulin resistance, and heightened cardiometabolic risk.